EP1622571A4 - Nucleinsäuren und entsprechende proteine mit der bezeichnung 109p1d4 zur behandlung und zum nachweis von krebs - Google Patents
Nucleinsäuren und entsprechende proteine mit der bezeichnung 109p1d4 zur behandlung und zum nachweis von krebsInfo
- Publication number
- EP1622571A4 EP1622571A4 EP04760669A EP04760669A EP1622571A4 EP 1622571 A4 EP1622571 A4 EP 1622571A4 EP 04760669 A EP04760669 A EP 04760669A EP 04760669 A EP04760669 A EP 04760669A EP 1622571 A4 EP1622571 A4 EP 1622571A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- cancer
- useful
- detection
- treatment
- nucleic acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46700203P | 2003-04-30 | 2003-04-30 | |
PCT/US2004/013568 WO2004098515A2 (en) | 2003-04-30 | 2004-04-30 | Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1622571A2 EP1622571A2 (de) | 2006-02-08 |
EP1622571A4 true EP1622571A4 (de) | 2012-05-02 |
Family
ID=33435005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04760669A Withdrawn EP1622571A4 (de) | 2003-04-30 | 2004-04-30 | Nucleinsäuren und entsprechende proteine mit der bezeichnung 109p1d4 zur behandlung und zum nachweis von krebs |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1622571A4 (de) |
JP (2) | JP2007525183A (de) |
AU (2) | AU2004235755A1 (de) |
CA (1) | CA2522994C (de) |
WO (1) | WO2004098515A2 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8010189B2 (en) | 2004-02-20 | 2011-08-30 | Brainsgate Ltd. | SPG stimulation for treating complications of subarachnoid hemorrhage |
US9233245B2 (en) | 2004-02-20 | 2016-01-12 | Brainsgate Ltd. | SPG stimulation |
US8055347B2 (en) | 2005-08-19 | 2011-11-08 | Brainsgate Ltd. | Stimulation for treating brain events and other conditions |
WO2006086345A2 (en) * | 2005-02-07 | 2006-08-17 | The Trustees Of Columbia University In The City Of New York | Methods to treat or prevent hormone-resistant prostate cancer using sirna specific for protocadherin-pc, or other inhibitors of protocadherin-pc expression or activity |
SG170780A1 (en) * | 2006-03-31 | 2011-05-30 | Alnylam Pharmaceuticals Inc | Compositions and methods for inhibiting expression of eg5 gene |
JP6236948B2 (ja) * | 2013-07-17 | 2017-11-29 | 東ソー株式会社 | 抗体精製用溶出液および当該溶出液を用いた抗体精製方法 |
EP2878335B1 (de) | 2013-11-10 | 2018-01-03 | Brainsgate Ltd. | Implantat und implantationssystem für nervenstimulator |
US11596652B2 (en) | 2015-02-18 | 2023-03-07 | Enlivex Therapeutics R&D Ltd | Early apoptotic cells for use in treating sepsis |
US11512289B2 (en) | 2015-02-18 | 2022-11-29 | Enlivex Therapeutics Rdo Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
WO2017141243A1 (en) | 2016-02-18 | 2017-08-24 | Enlivex Therapeutics Ltd. | Combination immune therapy and cytokine control therapy for cancer treatment |
US11000548B2 (en) | 2015-02-18 | 2021-05-11 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
US11318163B2 (en) | 2015-02-18 | 2022-05-03 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
US11497767B2 (en) | 2015-02-18 | 2022-11-15 | Enlivex Therapeutics R&D Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
US11304976B2 (en) | 2015-02-18 | 2022-04-19 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
CN113106053A (zh) | 2015-04-21 | 2021-07-13 | 恩立夫克治疗有限责任公司 | 治疗性汇集的血液凋亡细胞制剂与其用途 |
US10271907B2 (en) | 2015-05-13 | 2019-04-30 | Brainsgate Ltd. | Implant and delivery system for neural stimulator |
TWI795381B (zh) * | 2016-12-21 | 2023-03-11 | 比利時商健生藥品公司 | 作為malt1抑制劑之吡唑衍生物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002083921A2 (en) * | 2001-04-10 | 2002-10-24 | Agensys, Inc. | Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001057190A2 (en) * | 2000-02-03 | 2001-08-09 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
-
2004
- 2004-04-30 AU AU2004235755A patent/AU2004235755A1/en not_active Abandoned
- 2004-04-30 CA CA2522994A patent/CA2522994C/en not_active Expired - Fee Related
- 2004-04-30 EP EP04760669A patent/EP1622571A4/de not_active Withdrawn
- 2004-04-30 JP JP2006514206A patent/JP2007525183A/ja active Pending
- 2004-04-30 WO PCT/US2004/013568 patent/WO2004098515A2/en active Application Filing
-
2008
- 2008-09-05 AU AU2008212020A patent/AU2008212020B2/en not_active Ceased
-
2011
- 2011-02-04 JP JP2011023063A patent/JP2011152132A/ja active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002083921A2 (en) * | 2001-04-10 | 2002-10-24 | Agensys, Inc. | Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers |
Non-Patent Citations (2)
Title |
---|
CHEN MIN-WEI ET AL: "The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cells", ONCOGENE, NATURE PUBLISHING GROUP, GB, vol. 21, no. 51, 7 November 2002 (2002-11-07), pages 7861 - 7871, XP002599354, ISSN: 0950-9232 * |
YOSHIDA K ET AL: "Identification of a Novel Protocadherin Gene (PCDH11) on the Human XY Homology Region in Xq21.3", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 62, no. 3, 15 December 1999 (1999-12-15), pages 540 - 543, XP004444711, ISSN: 0888-7543, DOI: 10.1006/GENO.1999.6042 * |
Also Published As
Publication number | Publication date |
---|---|
WO2004098515A3 (en) | 2009-04-30 |
JP2007525183A (ja) | 2007-09-06 |
CA2522994A1 (en) | 2004-11-18 |
AU2008212020A1 (en) | 2008-09-25 |
JP2011152132A (ja) | 2011-08-11 |
EP1622571A2 (de) | 2006-02-08 |
CA2522994C (en) | 2012-09-25 |
WO2004098515A2 (en) | 2004-11-18 |
AU2004235755A1 (en) | 2004-11-18 |
AU2008212020B2 (en) | 2012-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1576130A4 (de) | Nukleinsäuren und entsprechende proteine mit der bezeichnung 282p1g3 mit eignung zur behandlung und zum nachweis von krebs | |
EP1572916A4 (de) | Nukleinsäure und entsprechendes protein mit der bezeichnung 98p4b6, geeignet zur behandlung und zum nachweis von krebs | |
HK1152714A1 (en) | Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer steap-1 | |
EP1537140A4 (de) | Zur behandlung und zum nachweis von krebs geeignete nukleinsäure und zugehöriges protein mit der bezeichnung 161p2f10b | |
AU2002318112B2 (en) | Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers | |
EP1622571A4 (de) | Nucleinsäuren und entsprechende proteine mit der bezeichnung 109p1d4 zur behandlung und zum nachweis von krebs | |
EP1649002A4 (de) | Rna prozessierende proteinkomplexe und verwendungen davon | |
EP1517606A4 (de) | Zur behandlung und zum nachweis von krebs geeignete nukleinsäure und zugehöriges protein mit der bezeichnung 193p1e1b | |
EP1590437A4 (de) | Für behandlung und nachweis von krebs geeignete nukleinsäuren und entsprechende proteine mit der bezeichnung 254p1d6b | |
PT1537140E (pt) | Ácido nucleico e proteína correspondente designada 161p2f10b úteis no tratamento e detecção de cancro | |
EP1372719A4 (de) | Nucleinsäure und entsprechendes protein mit der bezeichnung 125p5c8 zur behandlung und zum nachweis von krebs | |
AU2001285018A1 (en) | Nucleic acids and corresponding proteins entitled 83p2h3 and catrf2e11 useful in treatment and detection of cancer | |
EP1573023A4 (de) | Nukleinsäure und dieser entsprechendes, 162p1e6 genanntes, für die behandlung und den nachweis von krebs geeignetes protein | |
EP1565200A4 (de) | NUKLEINSûURE ENTSPRECHENDES PROTEIN 24P4C12 ZUR BEHANDLUNG UND ERKENNUNG VON KREBS | |
EP1539805A4 (de) | Zur behandlung und zum nachweis von krebs geeignete nukleinsäuren und entsprechende proteine mit der bezeichnung 101p3a11 oder phor-1 | |
AU2003268355A8 (en) | Localization of human cytomegalovirus nucleic acids and proteins in human cancer cells | |
EP1578980A4 (de) | Zur behandlung und zum nachweis von krebs geeignete nukleinsäure und entsprechendes protein mit der bezeichnung 213p1f11 | |
GB0118995D0 (en) | Detection of mutations in nucleic acids | |
EP1399174A4 (de) | Nukleinsäure und zugehöriges, zur behandlung und zum nachweis von krebs geeignetes protein mit der bezeichnung 121p1f1 | |
EP1545556A4 (de) | Nukleinsüure und entsprechendes protein 98p4b6 zur behandlung und zum nachweis von krebs | |
EP1499350A4 (de) | Nukleinsäure und zugehöriges protein mit der bezeichnung 205p1b5 zur verwendung bei der behandlung und zum nachweis von krebs | |
AU2001286541A1 (en) | Nucleic acids and corresponding proteins entitled phor1-a11 and phor1-f5d6 useful in treatment and detection of cancer | |
IL164390A0 (en) | Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer | |
ZA200501838B (en) | Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer | |
AU2012244341A1 (en) | Nucleic acids and corresponding proteins entitled 191P4D12(b) useful in treatment and detection of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20051129 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL HR LT LV MK |
|
DAX | Request for extension of the european patent (deleted) | ||
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: JAKOBOVITS, AYA Inventor name: KANNER, STEVEN, B. Inventor name: PEREZ-VILLAR, JUAN, J. Inventor name: GE, WANGMAO Inventor name: CHALLITA-EID, PIA, M. Inventor name: RAITANO, ARTHUR, B. |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: AGENSYS, INC. |
|
PUAK | Availability of information related to the publication of the international search report |
Free format text: ORIGINAL CODE: 0009015 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C07H 21/04 20060101ALI20090731BHEP Ipc: C07H 21/00 20060101ALI20090731BHEP Ipc: C12Q 1/68 20060101AFI20090731BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20120403 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C07K 14/47 20060101ALI20120328BHEP Ipc: C07K 14/705 20060101AFI20120328BHEP |
|
17Q | First examination report despatched |
Effective date: 20121029 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20140405 |